medigraphic.com

2019, Número 4

<< Anterior Siguiente >>

Rev Mex Anest 2019; 42 (4)


Manejo de líquidos en el perioperatorio: principios generales

Ortega-García JP, López-Ramírez AY

Idioma: Español
Referencias bibliográficas: 79
Paginas: 285-291
Archivo PDF: 301.34 Kb.


RESUMEN

La terapia de líquidos en el perioperatorio ha sido tema de amplia discusión y estudio en la última década. Partiendo de ideas y conceptos científicos cambiantes que intentan explicar y entender el comportamiento de los fluidos en el organismo, nos encontramos desde 1896 con el Principio de Starling explicando la fisiología de homeostasis de líquidos dentro y fuera de la capa de la superficie endotelial (CSE) hasta la época actual, donde gracias al conocimiento de la existencia del glucocálix o también llamado «protector de la membrana celular» hemos transformado y racionalizado la fluidoterapia perioperatoria y dejamos atrás conceptos como el reemplazo exagerado de pérdidas perioperatorias y nos enfocamos en terapia guiada por objetivos que optimicen la recuperación del paciente y disminuyan las complicaciones postoperatorias.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Lobo DN, Bostock KA, Neal KR, Perkins AC, Rowlands BJ, Allison SP. Effect of salt and water balance on recovery of gastrointestinal function after elective colonic resection a randomised controlled trial. Lancet. 2002;359:1312-1313.

  2. Thiele RM, Rea KM, Turreatine FE, et al. Standardization of care impact of an enhanced recovery protocol on length of stay complications, and direct costs after colorectal surgery. J Am Coll Surg. 2015;220:430-443.

  3. Varadhan KK, Lobo DN. A meta-analysis of randomised controlled trials of intravenous fluid therapy in major elective open abdominal surgery getting the balance right. Proc Nutr Soc. 2010;69:488-498.

  4. Gan TJ, Sopitt A, Maroof M, et al. Goal-directed intraoperative fluid administration reduces length of hospital stay after major surgery. Anesthesiology. 2002;97:820-826.

  5. De Jonge E, Levi M. Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med. 2001;29:1261-1267.

  6. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125-139.

  7. Permer A, Haase N, Guttomsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med. 2012;367:124-134.

  8. Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367:1901-1911.

  9. Le Tourmeau JL, Pinney J, Phiillips CR. Extravascular lung water predicts progression to acute lung injury in patients with increased risk. Crit Care Med. 2012;40:847-854.

  10. Marik PE. Iatrogenic salt water drowning and the hazards of a high central venous pressure. Ann Intensive Care. 2014;4:21.

  11. Cordemans C, De Laet I, Van Regenmortel N et al. Fluid management in critically ill patients: the role of extravascular lung water, abdominal hypertension, capillary leak and fluid balance. Ann Intensive Care 2012;2:S1.

  12. Daugherty EL, Hongyan Liang, Taichman D, et al. Abdominal compartment syndrome is common in medical intensive care unit patients receiving large- volume resuscitation. J Intensive Care Med. 2007; 22:294-299.

  13. Payen D, de Pont AC, Sakr Y, et al. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care 2008; 12:R74.

  14. Prowle JR, Echeverri JE, Ligabo EV, et al. Fluid balance and acute kidney injury. Nat Rev Nephrol 2010;6:107-115.

  15. Latta T. Saline venous injection in cases de malignant cholera, performed while in the vapour-bath. Lancet. 1832;19:173-176.

  16. Cook P, Bellis M. Knowing the risk. Public Health. 2001;115:54-61.

  17. Weiser TG, Regenbogen SE, Thompson KD, et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet. 2008;372:139-144.

  18. Pearse RM, Harrison Da, James P, et al. Identification and characterization of the high- risk surgical population in the United Kingdom. Crit Care. 2006;10:R81.

  19. Chappell D, Jacob M. Hydroxyethyl starch- the importance of being earnest. Scand J Trauma Resusc Emerg Med. 2013;21:61.

  20. Becker BF, Chappell D, Jacob M. Endothelial glycocalyx and coronary vascular permeability: the fringe benefit. Basic Res Cardiol. 2010;105:687-701.

  21. Chappell D, Jacob M, Hofmann-Kiefer K, et al. A rational approach to perioperative fluid management. Anesthesiology. 2008;109:723-740.

  22. Lamke LO, Nilsson GE, Reithner HL. Insensible perspiration from the skin under standardized environmental conditions. Scand J Clin Lab Invest. 1977;37:325-331.

  23. Jacob M, Chappell D, Conzen P, et al. Blood volume is normal after pre-operative overnight fasting. Acta Anaesthesiol Scand. 2008;52:522-529.

  24. Jacob M, Chappell D, Rehm M. The “third space”- fact or fiction? Best Pract Res Clin Anesthesiol. 2009;23:145-157.

  25. Jacob M, Chappell. Effects of perioperative fasting on haemodynamics and intravascular volumes. Best Pract Res Clin Anaesthesiol. 2012;26:421-430.

  26. Starling EH. On the absorption of fluids from the connective tissue spaces. J Physiol. 1896;19:312-326.

  27. Adamson RH, Lenz JF, Zhang X, et al. Oncotic pressures opposing filtration across non-fenestrated rat microvessels. J Physiol. 2004;557:889-907.

  28. Jacob M, Bruegger D, Rhem M, et al. The endothelial glycocalyx affords compatibility of Starling’s principle and high cardiac interstitial albumin levels. Cardiovasc Res. 2007;73:575-586.

  29. Pries AR, Secomb TW, Gaehtgens P. The endotelial surface layer. Pflugers Archiv Eur J Physiol. 2000;440:653-666.

  30. Chappell D, Dorfler N, Jacob M, et al. Glycocalyx protection reduces leukocyte adhesion after ischemia/reperfusion. Shock. 2010;34:133-139.

  31. Jacob M, Rehm M, Loetsch M, et al. The endothelial glycocalyx prefers albumin for evoking shear stress- induced, nitric oxide- mediated coronary dilatation. J Vasc Res. 2007;44:435-443.

  32. Nelson A, Berkestedt I, Schmidtchen A, et al. Increased levels of glycosaminoglycans during septic shock: relation to mortality and the antibacterial actions of plasma. Shock. 2008;30:623-627.

  33. Rehm M, Bruegger D, Christ F, et al. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation. 2007;116:1896-1906.

  34. Nieuwdorp M, Van Haeften TW, Gouverneur MC, et al. Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes. 2006;55:480-486.

  35. Rhem M, Haller M, Orth V, et al. Changes in blood volume and hematocrit during acute preoperative volume loading with 5% albumin or 6% hetastarch solutions in patients before radical hysterectomy. Anesthesiology. 2001;95:849-856.

  36. Johansson PI, Stensballe J, Rasmussen LS, et al. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis and increased mortality in trauma patients. Ann Surg, 2011;254:194-200.

  37. Ghada M. Implications of recent accumulating knowledge about endothelial glycocalyx on anesthetic management. J Anesth. 2015;29:269-278.

  38. Stoneham M, Hill E. Variability in postoperative fluid and electrolyte prescription. Br J Clin Pract. 1997;51:82-84.

  39. Cawla G, Drummond G. Water, strong ions, and weak ions. Contin Educ Anaesth Crit Care pain. 2008;8:108-112.

  40. Williams EL, Hildebrand KL, Mc Cormick SA, Bedel MJ. The effect of intravenous lactated Ringer’s solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers. Anesth Analg. 1999;88:999-1003.

  41. McFarlane C, Lee A. A comparison of plasmalyte 148 and 0.9% saline for intra-operative fluid replacement. Anaesthesia. 1994;49:779-781.

  42. Scheingraber S, Rhem M. Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery. Anesthesiology. 1999;90:1265-1270.

  43. Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte® 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 2012;256:18-24.

  44. Reid F, Lobo DN, Williams RN, et al. Hartmann’s solution: a randomized double-blind crossover study. Clin Sci (Lond). 2003;104:17-24.

  45. Shaw AD, BagsHaw SM, Goldstein SL, et al. Major complications, mortality and resource utilization after open abdominal surgery: 0.9% saline compared to plasma Lyte. Ann Surg. 2012;255:821-829.

  46. Mc Cluskey SA, Karkoutli K, Wijeysundera D, et al. Hyperchloremia after noncardiac surgery is independently associated with increased morbidity and mortality: a propensity-matched cohort study. Anesth Analg. 2013;117:412-421.

  47. O’Malley CMN, Frumento RJ, Hardy MA, et al. A randomized, double-blind comparison of lactated Ringer’s solution and 0.9% NaCl during renal transplantation. Anesth Analg. 2005;100:1518-1524.

  48. Nadeem A, Salahuddin N, El Hazmi A, et al. Chloride-liberal fluids are associated with acute kidney injury after liver transplantation. Crit Care. 2014;18:625.

  49. Mahler SA, Conrad SA, Wang H, Arnold TC. Resuscitation with balanced electrolyte solution prevents hyperchloremic metabolic acidosis in patients with diabetic ketoacidosis. Am J Emerg Med. 2011;29:670-674.

  50. Chua H-R, Venkatesh B Stachowski E, et al. Plasma Lyte 148 vs 0.9% saline for fluid resuscitation in diabetic ketoacidosis. J Crit Care. 2012;27:138-145.

  51. Yunos NM, Kim IB, Bellomo R, et al. The biochemical effects of restricting chloride-rich fluids in intensive care. Crit Care Med. 2011;39:2419-2424.

  52. Yunos NM, Bellomo R, Hegarty C, et al. Association between a chloride-liberal vs Chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. J Am Med Assoc. 2012;308:1566-1572.

  53. Raghunathan K, Shaw A, Nathanson B, et al. Association between the choice of iv crystalloid and in-hospital mortality among critically ill adults with sepsis. Crit Care Med. 2014;42:1585-1591.

  54. Cochrane injuries Group. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ. 1998;317:235-240.

  55. Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the Intensive Care Unit. N Engl J Med. 2004;350:2247-2256.

  56. Caironi P, Tognoni G, Masson S, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370:1412-1421.

  57. Bayer O, Reinhart K, Sakr Y, et al. Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: A prospective sequential comparison. Crit Care Med. 2011;39:1335-1342.

  58. Laxenaire MC, Chapentier C, Feldman L. Reactions anaphylactoides aux substituts colloidaux du plasma: incidence, facteurs de risque, mecanismes. Ann Fr Anesth Reanim. 1994;13:301-310.

  59. Marrel J, Christ D, Spahn DR. Anaphylactic shock after sensitization to gelatin. Br J Anaesth. 2011;107:647-648.

  60. Henriksen MG, Hessov I, Dela F, Hansen HV, Haraldsted V, et al. Effects of preoperative oral carbohydrates and peptides on postoperative endocrine response mobilization, nutrition and muscle function in abdominal surgery. Acta Anaesthesiol Scand. 2003;47:191-199.

  61. Soop M, Nygren J, Myrenfors P, Thorell A, Ljuggvist O. Preoperative oral carbohydrate treatment attenuates immediate postoperative insulin resistance. Am J Physiol Endocrinol Metab. 2001;208:76-83.

  62. Hausel J, Nygren J Lagerkranser M, et al. A carbohydrate-rich drink reduces preoperative discomfort in elective surgery patients. Anesth Analg. 2001;93:1344-1350.

  63. Holte K. Pathophysiology and clinical implications of perioperative fluid management in elective surgery. Dan Med Bull. 2010;57:B4 156.

  64. Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999;341:403-409.

  65. Myburrgh J, Cooper DJ, Finfer S, et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med. 2007;357:874-884.

  66. Gattas DJ, Dan A, Myburgh J, et al. Fluid resuscitation with 6% hydroxyethyl starch (130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy. Intensive Care Med. 2013;39:558-568.

  67. Hartog CS, Skupin H, Natanson C, et al. Systematic analysis of hydroxyethyl starch (HES) reviews: proliferation of low-quality reviews overwhelms the results of well-performed meta-analyses. Intensive Care Med. 2012;38:1258-1271.

  68. Antonelli M, Sandroni C. Hydroxyethyl starch for intravenous volume replacement: more harm than benefit. JAMA. 2013;309:723-724.

  69. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125-139.

  70. Wilkes MM, Navickis RJ, Sibbald WJ. Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding. Ann Thorac Surg. 2001;72:527-533.

  71. Perel P, Roberts I, Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2013;(2): CD000567.

  72. Reinhart K, Perner A, Sprung CL, et al. Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med. 2012;38:368-383.

  73. Berger MM, Gradwohl-Matis I, Brunauer A, Ulmer H, Dunser MW. Targets of perioperative fluid therapy and their effects on postoperative outcome: a systematic review and meta-analysis. Minerva Anestesiol. 2015;81:794-808.

  74. Jones AE, Shapiro NI, Trzeciak S, et al. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA. 2010;303:739-746.

  75. ARISE investigators, ANZICS Clinical Trials Group, Peake SL, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371:1496-1506.

  76. Mouncey PR, Osborn TM, Power GS, et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 2015;372:1301-1311.

  77. Saffle JR. The phenomenon of fluid creep in acute burn resuscitation. J Burn Care Res. 2007;28:382-395.

  78. Grams ME, Estrella MM, Coresh J, et al. Fluid balance, diuretic use and mortality in acute kidney injury. Clin J Am Soc Nephrol. 2011;6:966-973.

  79. Bellomo R. Issue and challenges of fluid removal in the critically ill. Br J Anaesth. 2014;113:734-735.




2020     |     www.medigraphic.com